Commercial hypothesisA subscription only makes sense if it saves repeated bid effort.
The current pricing test range is €49 / €79 / €129 per month, with €79 as the central hypothesis. These are validation points, not committed prices. Free discovery already exists; the paid hypothesis is that repeated, source-visible qualification and evidence-gap work is valuable enough to justify a subscription below heavier bid-management suites.
ActivationFirst useful bid/no-bid pack from a real tender.
RetentionSupplier returns for later opportunities or amendments.
Paid proofActual recurring payment, not stated interest.
Kill rule: do not turn this into a larger platform unless real suppliers repeatedly use the decision pack and at least one accepts paid recurring access. Internal builds, page views and stated interest are not traction.